Carl M. Gay, MD, PhD

Drs Carl M. Gay and Jared Weiss highlight several novel strategies that show promise in optimizing treatment for patients with small cell lung cancer and respond to questions from community oncologists who manage treatment for patients with lung cancer.

Available treatment options as second-line therapy for small cell lung cancer.

Current considerations that affect the choice of frontline therapy for patients with small cell lung cancer with the availability of novel systemic therapies.

Symptoms and risk factors associated with small cell lung cancer, and recommendations for staging patients with newly diagnosed disease.